Vera Therapeutics, Inc
VERA
NASDAQ
Biotechnology
$31.63
USD
+2.74 (+9.48%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $2.16B
Volume 5.9M
About Vera Therapeutics, Inc
The company is headquartered in Brisbane California, California and currently employs 249 full-time employees. The company went IPO on 2021-05-14.
CEO
Dr. Marshall Fordyce
HQ
Brisbane California, CALIFORNIA, US
Founded
2021
Employees
249
Key Metrics
2 metrics our research team weighs before forming a view on VERA.
Based on Quantli research · SEC filings · as of Q2 2026
METRIC
VALUE
CHANGE
TREND (3Y)
ROE (TTM)
-98.6%
—
Free Cash Flow (TTM)
$-338.91M
—
Financial Snapshot
Revenue
$0
— YoY
Gross Margin
—
— YoY
Net Income
$-401.89M
-84.1%
YoY
Operating Cash Flow
$-338.65M
-82.8%
YoY
Key Statistics
Open
$31.29
Previous Close
$28.89
Day Range
$29.73 - $32.31
52 Week Range
$21.04 - $56.05
Volume
5.9M
Average Volume (10 Days)
2.2M
Dividend Yield
—
Valuation Measurement
Market Cap
$2.16B
P/E Ratio (TTM)
—
Price / Book
5.30
Financial Highlights
Return on Assets
-75.4%
Return on Equity
-98.6%
Revenue (TTM)
$0
Net Income (TTM)
$-401.89M
Diluted EPS (TTM)
-$5.86
Total Cash (MRQ)
$48.88M
Levered FCF (TTM)
$-338.91M
Turn research into action
Knowing a stock is strong is the start. Knowing how to invest in it when you spot good research is good returns.
Similar Stocks
SLS
Sellas Life Sciences Group Inc
$12.78
▲ +3.4%
BCRX
BioCryst Pharmaceuticals Inc
$9.74
▼ -0.7%
PVLA
Palvella Therapeutics Inc
$156.13
▼ -0.3%
CDNA
CareDx Inc
$45.32
▼ -4.3%
VCEL
Vericel Corp
$44.20
▼ -0.8%
COAG
Hemab Therapeutics Holdings Inc
$54.94
▲ +1.8%
MLYS
Mineralys Therapeutics Inc
$25.64
▼ -1.7%
KLRA
Kailera Therapeutics Inc
$17.94
▼ -0.2%
Earnings Calendar
Next Earnings
Estimated Q3 Release
Nov 03
Est. EPS
Adjusted consensus estimate
-$1.54
Analyst Consensus
Based on 1 analyst ratings
Avg Target: $90.00
(+184.5% upside)
High: $90.00 · Low: $90.00
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%